CompletedNCT02969369
Safety study of SEP-363856 in Schizophrenia
This study is completed in the United States. It is testing SEP-363856 for Schizophrenia.
Multiple locations, including FresnoSchizophreniaOtherFrom 55 Years to 105 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT06136936
Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia
This study is completed in the United States. It is testing Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia.
In New YorkSchizophreniaOtherOver 18 Years
CompletedNCT01206517
Safety study of sublingual Asenapine in schizophrenia
This study is completed in Global. It is testing sublingual Asenapine for schizophrenia.
In GlobalBipolarity, SchizophreniaOtherFrom 10 Years to 17 Years
CompletedNCT06024239
Safety study of Pharmacokinetics, Safety, and Tolerability of ABBV-932 in anxiety
This study is completed in the United States. It is testing Pharmacokinetics, Safety, and Tolerability of ABBV-932 for anxiety.
Multiple locations, including Los AlamitosBipolarity, AnxietyOtherFrom 18 Years to 65 Years
CompletedNCT03745820
Safety study of Safety and Efficacy of BIIB104 in schizophrenia
This study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.
Multiple locations, including BentonvilleSchizophreniaOtherFrom 18 Years to 55 Years
WithdrawnNCT06878833
Safety study of Long-Acting Oral Risperidone in schizophrenia
This study was withdrawn in Global. It is testing Long-Acting Oral Risperidone for schizophrenia.
In GlobalSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT06107803
Safety study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in schizophrenia
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine for schizophrenia.
Multiple locations, including Garden GroveSchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT01624649
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
This study is completed. It focuses on ADHD and currently lists study information in South Korea.
Multiple locations, including Bucheon-Si Gyeonggi-DoADHDOtherFrom 6 Years to 15 Years
CompletedNCT06570369
A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression
This study is completed in the United States. It focuses on depression.
Multiple locations, including Garden GroveDepressionOtherFrom 18 Years to 60 Years
Active Not RecruitingNCT06785012
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
This study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
Multiple locations, including HuntsvilleDepressionOtherFrom 18 Years to 64 Years
CompletedNCT00224510
A Study To Investigate The Antidepressant Effect Of Lamotrigine In people with Bipolarity Using Lithium
This study is completed. It focuses on bipolarity and currently lists study information in the Netherlands and Spain.
Multiple locations, including AlkmaarBipolarity, DepressionOtherOver 18 Years
CompletedNCT06225115
Safety study of KYN-5356 in Schizophrenia
This study is completed in the United States. It is testing KYN-5356 for Schizophrenia.
In GlendaleSchizophreniaOtherFrom 18 Years to 55 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.